ProShares Ultra NASDAQ Biotechnology
BIB
BIB
24 hedge funds and large institutions have $19.4M invested in ProShares Ultra NASDAQ Biotechnology in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
51% less call options, than puts
Call options by funds: $24.9M | Put options by funds: $51.2M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
24
Holding in Top 10
1
Calls
$24.9M
Puts
$51.2M
Top Buyers
| 1 | +$3.24M | |
| 2 | +$1.12M | |
| 3 | +$577K | |
| 4 |
WSTAM
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
+$474K |
| 5 |
BHA
Beech Hill Advisors
New York
|
+$437K |
Top Sellers
| 1 | -$6.46M | |
| 2 | -$1.69M | |
| 3 | -$1.42M | |
| 4 |
OPPM
Opus Point Partners Management
New York
|
-$1.21M |
| 5 |
Jane Street
New York
|
-$664K |